Neuronal development genes are key elements mediating the reinforcing effects of methamphetamine, amphetamine, and methylphenidate

Psychopharmacology

Volumn 230, Issue 3, 2013, Pages 399-413

  Dela Peña, Ike ^a   Jeon, Se Jin ^c   Lee, Eunyoung ^b   Ryu, Jong Hoon ^d   Shin, Chan Young ^c   Noh, Minsoo ^b   Cheong, Jae Hoon ^a  

^a Sahmyook University   (South Korea)

^b Ajou University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Gene expression; Neuronal development genes; Psychostimulants

Indexed keywords

AMPHETAMINE; CALGRANULIN A; CALGRANULIN B; METHAMPHETAMINE; METHYLPHENIDATE; NEUROGENIC DIFFERENTIATION FACTOR; NUCLEAR RECEPTOR RELATED FACTOR 1; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TRANSCRIPTION FACTOR MSX1;

ALAS1 GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BHLHE22 GENE; BRAIN DEVELOPMENT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABUSE; DRUG SELF ADMINISTRATION; GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; MALE; MSX1 GENE; NERVE CELL PLASTICITY; NEUROD1 GENE; NONHUMAN; NR4A2 GENE; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; S100A8 GENE; S100A9 GENE; SGK1 GENE; UPREGULATION;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; METHAMPHETAMINE; METHYLPHENIDATE; MICE; MORPHINE; NEURONAL PLASTICITY; RATS; RATS, WISTAR; REINFORCEMENT SCHEDULE; REWARD; SELF ADMINISTRATION; TRANSCRIPTOME;

EID: 84888646344     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3168-8     Document Type: Article

References (61)

1. Adler MW, Rogers TJ (2005) Are chemokines the third major system in the brain? J Leukoc Biol 78(6):1204-1209
2. Albertson TE, Derlet RW, Van Hoozen BE (1999) Methamphetamine and the expanding complications of amphetamines. West J Med 170:214-219
3. Ang SL (2006) Transcriptional control of midbrain dopaminergic neuron development. Development 133:3499-3506
4. Baldwin HA, Colado MI, Murray TK, De Souza RJ, Green AR (1993) Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine. Br J Pharmacol 108:590-596
5. Beckman DA, Schneider M, Youreneff M, Tse FF (2008) Juvenile toxicity assessment of d,l-methylphenidate in rats. Birth Defects Res B Dev Reprod Toxicol 83(1):48-67
6. Berman SM, Kuczenski R, McCracken JT, London ED (2009) Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry 14(2):123-142
7. Cadet JL (2009) Amphetamine recapitulates developmental programs in the zebrafish. Genome Biol 10:231
8. Childress AR, McElgin W, Mozley PD, O'Brien CP (1999) Limbic activation during cue-induced craving for cocaine and for natural rewards. Biol Psychiatry 45:170
9. Clark KH, Wiley CA, Bradberry CW (2013) Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection. Neurotox Res 23(2):174-188
10. Compton WM, Volkow ND (2006) Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 83(Suppl 1):S4-S7
11. dela Peña I, Lee JC, Lee HL, Woo TS, Lee HC, Sohn AR, Cheong JH (2012a) Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment. Neurosci Lett 514(2):189-193
12. dela Peña I, Yoon SY, Lee JC, dela Peña JB, Sohn AR, Ryu JH, Shin CY, Cheong JH (2012b) Methylphenidate treatment in the spontaneously hypertensive rat: influence on methylphenidate self-administration and reinstatement in comparison with Wistar rats. Psychopharmacology (Berlin) 221(2):217-226
13. Filloux F, Townsend JJ (1993) Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 119:79-88
14. Flames N, Hobert O (2011) Transcriptional control of the terminal fate of monoaminergic neurons. Annual Rev Neurosci 34:153-184
15. Folds Mathes W, Nehrenberg DL, Gordon R, Hua K, Garland J, Pomp D (2010) Dopaminergic dysregulation in mice selectively bred for excessive exercise of obesity. Behav Brain Res 210(2):155-163
16. Freeman WM, Lull ME, Patel KM, Brucklacher RM, Morgan D et al (2010) Gene expression changes in the medial prefrontal cortex and nucleus accumbens following abstinence from cocaine self-administration. BMC Neurosci 11:29
17. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM (2003) It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26:184-192
18. Greco D, Volpicelli F, Di Lieto A, Leo D, Perrone-Capano C (2009) Comparison of gene expression profile in embryonic mesencephalon and neuronal primary cultures. PLoSOne 4(3):e4977
19. Jacobs EH, Smit AB, de Vries TJ, Schoffelmeer AN (2003) Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol Sci 24(11):566-573
20. Jones JR, Caul WF (1992) Effects of amphetamine on food intake and weight: timing of injections and food access. Physiol Behav 52(3):515-520
21. Joshi PS, Molyneaux BJ, Feng L, Xie X, Macklis JD, Gan L (2008) Bhlhb5 regulates the postmitotic acquisition of area identities in layers II-V of the developing neocortex. Neuron 60(2):258-272
22. Kadkhodaei B, Ito T, Joodmardi E, Mattson B, Rouillard C et al (2009) Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J Neurosci 29:15923-15932
23. Kalivas PW (2005) How do we determine which drug-induced neuroplastic changes are important? Nat Neurosci 8(11):1440-1441
24. Kelley AE (2004) Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44:161-179
25. Kest B, Palmese CA, Hopkins E, Adler M, Juni A, Mogil JS (2002) Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115:463-469
26. Koob GF (2008) A role for brain stress systems in addiction. Neuron 59(1):11-34
27. Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217-238
28. Korostynski M, Piechota M, Kaminska D, Solecki W, Przewlocki R (2007) Morphine effects on striatal transcriptome in mice. Genome Biol 8:R128
29. Krasnova IN, Li SM, Wood WH, McCoy MT, Prabhu VV, Becker KG, Katz JL, Cadet JL (2008) Transcriptional responses to reinforcing effects of cocaine in the rat hippocampus and cortex. Genes Brain Behav 7(2):193-202
30. Krasnova IN, Justinova Z, Ladenheim B, Jayanthi S, McCoy MT et al (2010) Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS One 5:e8790
31. Krasnova IN, Ladenheim B, Hodges AB, Volkow ND, Cadet JL (2011) Chronic methamphetamine administration causes differential regulation of transcription factors in the rat midbrain. PloS One 6(4):e19179
32. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402-408
33. Loftis J (2011) Methamphetamine causes persistent immune dysregulation: a cross-species, translational report. Neurotox Res 20(1):59-68
34. Lull ME, Freeman WM, Vrana KE, Mash DC (2008) Correlating human and animal studies of cocaine abuse and gene expression. Ann N Y Acad Sci 1141:58-75
35. Mariotti KC, Rossato LG, Froehlich PE, Limberger RP (2013) Amphetamine-type medicines: a review of pharmacokinetics, pharmacodynamics and toxicological aspects. Curr Clin Pharmacol (in press)
36. Martinat C, Bacci JJ, Leete T, Kim J, Vanti WB et al (2006) Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci USA 103:2874-2879
37. Muñoz EM, Bailey MJ, Rath MF, Shi Q, Morin F, Coon SL, Møller M, Klein DC (2007) NeuroD1: developmental expression and regulated genes in the rodent pineal gland. J Neurochem 102(3):887-899
38. Nacken W, Roth J, Sorg C, Kerkhoff C (2003) S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 60(6):569-580
39. Paxinos G, Watson C (1996) The rat brain in stereotaxic coordinates. Academic, New York
40. Piechota M, Korostynski M, Solecki W, Gieryk A, Slezak M, Bilecki W, Ziolkowska B et al (2010) The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum. Genome Biol 11:R48
41. Piechota M, Korostynski M, Sikora M, Golda S, Dzbek J (2012) Common transcriptional effects in the mouse sttiatum following chronic treatment with heroin and methamphetamine. Genes Brain Behav 11:404-414
42. Renthal W, Kumar A, Xiao G, Wilkinson M, Covington HE 3rd, Maze I, Sikder D, Robison AJ, LaPlant Q, Dietz DM, Russo SJ, Vialou V, Chakravarty S, Kodadek TJ, Stack A, Kabbaj M, Nestler EJ (2009) Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 62:335-348
43. Rhodes JS, Crabbe JC (2005) Gene expression induced by drugs of abuse. Curr Opin Pharmacol 5(1):26-33
44. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
45. Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev 12:623-637
46. Sadasivan S, Pond BB, Pani AK, Qu C, Jiao Y, Smeyne RJ (2012) Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice. Plos One 7(3):333693
47. Sagvolden T (2000) Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31-39
48. Tande D, Hoglinger G, Debeir T, Freundlieb N, Hirsch E, Francois C (2006) New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Brain 129:1194-1200
49. Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM (2004) Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 311(1):1-7
50. Todd RD (1992) Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biol Psychiatry 31:794-807
51. Tripodi M, Filosa A, Armentano M, Studer M (2004) The COUP-TF nuclear receptors regulate cell migration in the mammalian basal forebrain. Development 131(24):6119-6129
52. Valjent E, Pages C, Herve D, Girault JA, Caboche J (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19:1826-1836
53. Volkow ND, Swanson JM (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 160(11):1909-1918
54. Webb K, Norton W, Trümbach D, Meijer AH, Ninkovic J, Topp S, Heck H et al (2009) Zebrafish reward mutants reveal novel transcripts mediating the behavioral effects of amphetamine. Genome Biol 10(7):R81
55. Werme M, Hermanson E, Carmine A, Buervenich S, Zetterstrom RH, Thoren P, Ogren SO, Olson L, Perlmann T, Brene S (2003) Decreased ethanol preference and wheel running in Nurr1-deficient mice. Eur J Neurosci 17:2418-2424
56. Whitney NP, Eidem TM, Peng H, Huang YL, Zheng JC (2009) Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injusry and neurodegenerative disorders. J Neurochem 108(6):1343-1359
57. Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229-240
58. Yuferov V, Nielsen D, Butelman E, Kreek MJ (2005) Microarray studies of psychostimulant-induced changes in gene expression. Addict Biol 10(1):101-118
59. Yui S, Nakatani Y Mikami (2003) Calprotectin (S100a8/S100a9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 26(6):753-760
60. Zhang F, Shen G, Liu XL, Wang F, Zhao HL, Yu J, Zhang JW (2011) Hypoxic induction of human erythroid-specific δ-aminolevulinate synthase mediated by hypoxia-inducible factor 1. Biochemistry 50(7):1194-1202
61. Zhou FC, Zhao Q, Liu Y, Goodlett CR, Liang T, McClintick JN, Edenberg HJ, Li L (2011) Alteration of gene expression by alcohol exposure at early neurulation. BMC Genomics 12:124